Logo image of OMCL

OMNICELL INC (OMCL) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:OMCL - US68213N1090 - Common Stock

40.495 USD
+0.88 (+2.23%)
Last: 12/5/2025, 8:00:01 PM
40.495 USD
0 (0%)
After Hours: 12/5/2025, 8:00:01 PM
Fundamental Rating

4

Overall OMCL gets a fundamental rating of 4 out of 10. We evaluated OMCL against 187 industry peers in the Health Care Equipment & Supplies industry. OMCL has an average financial health and profitability rating. OMCL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year OMCL was profitable.
OMCL had a positive operating cash flow in the past year.
OMCL had positive earnings in 4 of the past 5 years.
Each year in the past 5 years OMCL had a positive operating cash flow.
OMCL Yearly Net Income VS EBIT VS OCF VS FCFOMCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

OMCL has a better Return On Assets (1.02%) than 75.13% of its industry peers.
OMCL has a Return On Equity of 1.63%. This is in the better half of the industry: OMCL outperforms 75.66% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.98%, OMCL is in the better half of the industry, outperforming 67.20% of the companies in the same industry.
Industry RankSector Rank
ROA 1.02%
ROE 1.63%
ROIC 0.98%
ROA(3y)-0.02%
ROA(5y)1.07%
ROE(3y)-0.07%
ROE(5y)1.98%
ROIC(3y)N/A
ROIC(5y)N/A
OMCL Yearly ROA, ROE, ROICOMCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6

1.3 Margins

OMCL's Profit Margin of 1.69% is fine compared to the rest of the industry. OMCL outperforms 75.66% of its industry peers.
OMCL's Profit Margin has declined in the last couple of years.
OMCL's Operating Margin of 1.57% is fine compared to the rest of the industry. OMCL outperforms 67.20% of its industry peers.
In the last couple of years the Operating Margin of OMCL has declined.
The Gross Margin of OMCL (43.82%) is worse than 64.02% of its industry peers.
In the last couple of years the Gross Margin of OMCL has declined.
Industry RankSector Rank
OM 1.57%
PM (TTM) 1.69%
GM 43.82%
OM growth 3Y-60.62%
OM growth 5Y-43.72%
PM growth 3Y-45.27%
PM growth 5Y-30.27%
GM growth 3Y-4.46%
GM growth 5Y-2.57%
OMCL Yearly Profit, Operating, Gross MarginsOMCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OMCL is destroying value.
OMCL has more shares outstanding than it did 1 year ago.
OMCL has more shares outstanding than it did 5 years ago.
OMCL has a better debt/assets ratio than last year.
OMCL Yearly Shares OutstandingOMCL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
OMCL Yearly Total Debt VS Total AssetsOMCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.54 indicates that OMCL is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.54, OMCL is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
The Debt to FCF ratio of OMCL is 1.78, which is an excellent value as it means it would take OMCL, only 1.78 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of OMCL (1.78) is better than 88.89% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that OMCL is not too dependend on debt financing.
OMCL's Debt to Equity ratio of 0.14 is fine compared to the rest of the industry. OMCL outperforms 62.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.78
Altman-Z 2.54
ROIC/WACC0.14
WACC7.08%
OMCL Yearly LT Debt VS Equity VS FCFOMCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.44 indicates that OMCL should not have too much problems paying its short term obligations.
The Current ratio of OMCL (1.44) is worse than 76.72% of its industry peers.
A Quick Ratio of 1.21 indicates that OMCL should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.21, OMCL is doing worse than 68.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.21
OMCL Yearly Current Assets VS Current LiabilitesOMCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.27% over the past year.
The Earnings Per Share has been decreasing by -9.56% on average over the past years.
The Revenue has grown by 10.67% in the past year. This is quite good.
Measured over the past years, OMCL shows a small growth in Revenue. The Revenue has been growing by 4.40% on average per year.
EPS 1Y (TTM)27.27%
EPS 3Y-23.52%
EPS 5Y-9.56%
EPS Q2Q%-8.93%
Revenue 1Y (TTM)10.67%
Revenue growth 3Y-0.59%
Revenue growth 5Y4.4%
Sales Q2Q%9.99%

3.2 Future

The Earnings Per Share is expected to grow by 8.18% on average over the next years. This is quite good.
OMCL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.77% yearly.
EPS Next Y2.6%
EPS Next 2Y5%
EPS Next 3Y8.18%
EPS Next 5YN/A
Revenue Next Year7.19%
Revenue Next 2Y5.57%
Revenue Next 3Y5.2%
Revenue Next 5Y3.77%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
OMCL Yearly Revenue VS EstimatesOMCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
OMCL Yearly EPS VS EstimatesOMCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

OMCL is valuated rather expensively with a Price/Earnings ratio of 22.25.
OMCL's Price/Earnings ratio is rather cheap when compared to the industry. OMCL is cheaper than 80.95% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.49. OMCL is around the same levels.
OMCL is valuated rather expensively with a Price/Forward Earnings ratio of 21.61.
79.37% of the companies in the same industry are more expensive than OMCL, based on the Price/Forward Earnings ratio.
OMCL is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.25
Fwd PE 21.61
OMCL Price Earnings VS Forward Price EarningsOMCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OMCL is valued a bit cheaper than 77.78% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, OMCL is valued cheaper than 89.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.39
EV/EBITDA 19.03
OMCL Per share dataOMCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates OMCL does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)8.56
PEG (5Y)N/A
EPS Next 2Y5%
EPS Next 3Y8.18%

0

5. Dividend

5.1 Amount

OMCL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OMNICELL INC

NASDAQ:OMCL (12/5/2025, 8:00:01 PM)

After market: 40.495 0 (0%)

40.495

+0.88 (+2.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-04 2026-02-04/amc
Inst Owners103.09%
Inst Owner Change-3.93%
Ins Owners1.85%
Ins Owner Change-0.57%
Market Cap1.82B
Revenue(TTM)1.18B
Net Income(TTM)19.92M
Analysts77.14
Price Target48.28 (19.22%)
Short Float %4.95%
Short Ratio5.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)53.27%
Min EPS beat(2)37.93%
Max EPS beat(2)68.6%
EPS beat(4)4
Avg EPS beat(4)33.07%
Min EPS beat(4)1.42%
Max EPS beat(4)68.6%
EPS beat(8)8
Avg EPS beat(8)81.98%
EPS beat(12)12
Avg EPS beat(12)124.86%
EPS beat(16)14
Avg EPS beat(16)94.65%
Revenue beat(2)2
Avg Revenue beat(2)3.31%
Min Revenue beat(2)3.03%
Max Revenue beat(2)3.59%
Revenue beat(4)4
Avg Revenue beat(4)2.18%
Min Revenue beat(4)0.42%
Max Revenue beat(4)3.59%
Revenue beat(8)6
Avg Revenue beat(8)1.88%
Revenue beat(12)9
Avg Revenue beat(12)1.78%
Revenue beat(16)9
Avg Revenue beat(16)0.53%
PT rev (1m)7.58%
PT rev (3m)7.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.03%
EPS NY rev (1m)2.93%
EPS NY rev (3m)10.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.12%
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)3.07%
Valuation
Industry RankSector Rank
PE 22.25
Fwd PE 21.61
P/S 1.54
P/FCF 19.39
P/OCF 11.86
P/B 1.49
P/tB 7.12
EV/EBITDA 19.03
EPS(TTM)1.82
EY4.49%
EPS(NY)1.87
Fwd EY4.63%
FCF(TTM)2.09
FCFY5.16%
OCF(TTM)3.41
OCFY8.43%
SpS26.24
BVpS27.2
TBVpS5.69
PEG (NY)8.56
PEG (5Y)N/A
Graham Number33.38
Profitability
Industry RankSector Rank
ROA 1.02%
ROE 1.63%
ROCE 1.24%
ROIC 0.98%
ROICexc 1.14%
ROICexgc 4.55%
OM 1.57%
PM (TTM) 1.69%
GM 43.82%
FCFM 7.96%
ROA(3y)-0.02%
ROA(5y)1.07%
ROE(3y)-0.07%
ROE(5y)1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-30.61%
ROICexc growth 3Y-63.57%
ROICexc growth 5Y-44.11%
OM growth 3Y-60.62%
OM growth 5Y-43.72%
PM growth 3Y-45.27%
PM growth 5Y-30.27%
GM growth 3Y-4.46%
GM growth 5Y-2.57%
F-Score8
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.78
Debt/EBITDA 1.81
Cap/Depr 80.78%
Cap/Sales 5.05%
Interest Coverage 250
Cash Conversion 166.26%
Profit Quality 470.63%
Current Ratio 1.44
Quick Ratio 1.21
Altman-Z 2.54
F-Score8
WACC7.08%
ROIC/WACC0.14
Cap/Depr(3y)65.69%
Cap/Depr(5y)73.35%
Cap/Sales(3y)4.74%
Cap/Sales(5y)5.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.27%
EPS 3Y-23.52%
EPS 5Y-9.56%
EPS Q2Q%-8.93%
EPS Next Y2.6%
EPS Next 2Y5%
EPS Next 3Y8.18%
EPS Next 5YN/A
Revenue 1Y (TTM)10.67%
Revenue growth 3Y-0.59%
Revenue growth 5Y4.4%
Sales Q2Q%9.99%
Revenue Next Year7.19%
Revenue Next 2Y5.57%
Revenue Next 3Y5.2%
Revenue Next 5Y3.77%
EBIT growth 1Y185.87%
EBIT growth 3Y-60.85%
EBIT growth 5Y-41.24%
EBIT Next Year101.89%
EBIT Next 3Y34.9%
EBIT Next 5YN/A
FCF growth 1Y-43.22%
FCF growth 3Y-8.04%
FCF growth 5Y10.13%
OCF growth 1Y-31.85%
OCF growth 3Y-6.79%
OCF growth 5Y5.3%

OMNICELL INC / OMCL FAQ

What is the ChartMill fundamental rating of OMNICELL INC (OMCL) stock?

ChartMill assigns a fundamental rating of 4 / 10 to OMCL.


What is the valuation status for OMCL stock?

ChartMill assigns a valuation rating of 4 / 10 to OMNICELL INC (OMCL). This can be considered as Fairly Valued.


What is the profitability of OMCL stock?

OMNICELL INC (OMCL) has a profitability rating of 4 / 10.


Can you provide the financial health for OMCL stock?

The financial health rating of OMNICELL INC (OMCL) is 5 / 10.


What is the earnings growth outlook for OMNICELL INC?

The Earnings per Share (EPS) of OMNICELL INC (OMCL) is expected to grow by 2.6% in the next year.